Assistant Professor at Mazandaran University of Medical Sciences, Sari, Iran
Dr. Seyedeh Masoumeh Seyedhosseini Tamijani is a dedicated neuroscientist whose work bridges the realms of neurophysiology, addiction studies, and cognitive neuroscience. With a solid foundation in midwifery and physiology, she transitioned into neuroscience to address complex neurobiological questions, particularly in neurodegeneration, neuroprotection, and addiction-related disorders. Her academic journey, practical research experience, and teaching portfolio reflect a comprehensive understanding of both the biological and behavioral underpinnings of neurological diseases. Throughout her career, she has contributed significantly to experimental neuroscience using molecular, cellular, and behavioral methods, making her a prominent figure in the Iranian neuroscience research community.
Profile
Scopus
Education
Dr. Tamijani began her academic career with a Bachelor of Science degree in Midwifery from Gilan University of Medical Sciences (2000–2004). Motivated to deepen her scientific knowledge, she pursued a Master of Science in Physiology at Mashhad University of Medical Sciences (2007–2010), where she developed an interest in neuroendocrinology. Her academic aspirations culminated in a Ph.D. at the Neuroscience Research Center, Shahid Beheshti University of Medical Sciences (2012–2017), where she focused on neural mechanisms underlying addiction and cognitive function. Her multidisciplinary educational background uniquely positioned her to explore neurochemical and behavioral dimensions of brain health and disease.
Experience
Dr. Tamijani possesses extensive laboratory experience across several domains including cellular studies (e.g., primary and lymphocyte cultures), molecular biology techniques (such as RT-PCR and DNA/RNA electrophoresis), and proteomics methods like immunohistochemistry and Western blotting. She has conducted numerous animal surgeries and behavioral experiments, including memory and anxiety-related tasks such as the Y-maze, open field, and novel object recognition tests. Beyond the lab, she has contributed to academia through teaching physiology, neurobiology, and experimental neuroscience to students ranging from undergraduates to Ph.D. candidates. Her teaching spans various institutions, including Mashhad University, Mazandaran University, and neuroscience summer schools organized by IBRO/APRC.
Research Interest
Dr. Tamijani’s research interests are rooted in understanding the mechanisms of neurodegeneration and neuroprotection in disorders such as Alzheimer’s and drug-induced cognitive decline. She is particularly focused on the neural and hormonal mechanisms underlying addiction, especially methamphetamine-related neurotoxicity, and the role of neuroendocrine hormones like thyroid, estrogen, and progesterone in cognitive function. She also explores the therapeutic potential of non-invasive neuromodulation techniques such as vagus nerve and peripheral nerve stimulation, bridging the gap between bench research and clinical application.
Award
Though specific awards are not explicitly listed, Dr. Tamijani’s repeated participation and oral/poster presentations at national and international conferences—including the Basic and Clinical Neuroscience Congress, Addiction Science Congress, and Iranian Congress of Physiology and Pharmacology—reflect recognition from the scientific community. Her role as a speaker on neuroendocrine protection in methamphetamine-induced models, and her engagement in collaborative research on hormonal modulation and neuromodulation, underline her influence in advancing neuroscience research in Iran.
Publication
Dr. Tamijani has published extensively on the neurochemical and cognitive effects of methamphetamine, hormonal therapy, and novel therapeutic techniques. Notable publications include:
Thyroid hormone treatment alleviates the impairments of neurogenesis, mitochondrial biogenesis and memory performance induced by methamphetamine (NeuroToxicology, 2019), cited by 27 articles.
Intranasal insulin treatment restores cognitive deficits and insulin signaling impairment induced by repeated methamphetamine exposure (Journal of Cellular Biochemistry, 2017), cited by 19 articles.
Thyroid hormones: possible roles in epilepsy pathology (Seizure, 2015), cited by 23 articles.
The effect of Crocus sativus extract on human lymphocytes’ cytokines and T helper 2/T helper 1 balance (Journal of Medicinal Food, 2011), cited by 32 articles.
Implication of thyroid hormone receptors in methamphetamine neurocognitive effects (NeuroToxicology, 2022), cited by 11 articles.
Vagus nerve stimulation in the treatment of nervous system disease: a review article (Tehran University Medical Journal, 2022), cited by 5 articles.
A review on novel object recognition disruptions induced by methamphetamine (Addiction and Health, 2023), a recent addition expected to gather impact.
Conclusion
Dr. Seyedeh Masoumeh Seyedhosseini Tamijani’s work embodies the intersection of molecular neuroscience, behavioral pharmacology, and therapeutic innovation. With a strong emphasis on addiction-related neurotoxicity and neuroprotection through hormonal and neuromodulatory interventions, she contributes meaningfully to understanding and mitigating cognitive dysfunction. Her multi-level research—from molecular pathways to behavior—offers translational insights into treatment strategies for neurological disorders. As both a scientist and educator, she continues to influence the next generation of neuroscientists and remains a vital contributor to the evolving landscape of brain research.